Stocks and Investing Stocks and Investing
Fri, January 24, 2020
Thu, January 23, 2020

Matthew Taylor Maintained (ABT) at Strong Buy with Increased Target to $105 on, Jan 23rd, 2020


Published on 2024-10-26 20:39:08 - WOPRAI, Matthew Taylor
  Print publication without navigation


Matthew Taylor of UBS, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $99 to $105 on, Jan 23rd, 2020.

Matthew has made no other calls on ABT in the last 4 months.



There are 3 other peers that have a rating on ABT. Out of the 3 peers that are also analyzing ABT, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Pasquale of "Guggenheim" Downgraded from Strong Buy to Hold on, Thursday, January 2nd, 2020


These are the ratings of the 2 analyists that currently disagree with Matthew


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $101 on, Tuesday, December 17th, 2019
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Thursday, October 17th, 2019

Contributing Sources